|Bid||19.70 x 900|
|Ask||19.99 x 3200|
|Day's Range||19.45 - 20.73|
|52 Week Range||15.50 - 24.75|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||38.22|
|Earnings Date||Feb 08, 2022 - Feb 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||27.17|
The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?
The stock market is highly volatile now. Robotic-assisted surgery is the future of surgery, and Intuitive Surgical (NASDAQ: ISRG) is already dominating the space. Biotech company Exelixis (NASDAQ: EXEL) and internet retail company Etsy (NASDAQ: ETSY) also have remarkable growth prospects that could bring in some exciting long-term returns.
With its stock down 11% over the past month, it is easy to disregard Exelixis (NASDAQ:EXEL). But if you pay close...